Hydrogen bond aromatic amide molecular cage compound as well as preparation method and application thereof

Through the design of hydrogen-bonded aramid molecular cage compounds, nitrogen atoms and pyridine-N atoms are used to form charge transfer complexes, and combined with intramolecular hydrogen bonds, the problems of iodine adsorption materials easily aging and low adsorption capacity in the prior art are solved. Achieve efficient and stable iodine capture effect.

CN118978656AActive Publication Date: 2024-11-19SICHUAN UNIV

Patent Information

Application Number
CN202411285997.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-11-19
Estimated Expiration
2044-09-13

AI Technical Summary

Technical Problem

In the prior art, radioactive iodine adsorption materials are prone to aging, have low iodine adsorption capacity, slow adsorption kinetics, poor solubility and poor structural stability, which limit their application in nuclear fission product treatment.

Method used

Develop a hydrogen-bonded aramid molecular cage compound that introduces lone pair electrons and pyridine-N atoms through nitrogen atoms to form a strong charge transfer complex, which combines intramolecular hydrogen bonds to enhance the adsorption capacity of iodine and improves the side chain modification Adsorption capacity.

Benefits of technology

It achieves high adsorption capacity, fast adsorption kinetics and high chemical stability, and can efficiently capture iodine vapor and organic iodine in harsh environments, and is suitable for iodine capture under nuclear industry conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978656A_ABST
    Figure CN118978656A_ABST
Patent Text Reader

Abstract

The invention discloses a hydrogen bond aromatic amide molecular cage compound as well as a preparation method and application thereof, and belongs to the technical field of porous organic functional materials. According to the method, an imine intermediate is synthesized through dynamic covalent chemical imine condensation reaction of a hydrogen bond oligomeric aromatic amide diamine monomer and a trialdehyde monomer in dichloromethane, then NaBH3CN is used for reduction through an in-situ one-pot method, the aromatic amide cage-shaped molecule is finally prepared, the preparation method is simple and convenient, and the reaction monomer is low in price and easy to obtain. Meanwhile, the prepared hydrogen bond aromatic amide molecular cage compound has high thermal stability and high chemical stability, can efficiently adsorb iodine (including I2, I3-and CH3I) in a solution state and a gas phase form, and can be applied to design and development of high-performance radioactive iodine capture materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of porous organic functional materials, and in particular relates to a hydrogen-bonded aromatic amide molecular cage compound and a preparation method and application thereof. Background Art

[0002] Radioactive iodine (eg 129 I and 131 I) As a nuclear power plant 239 Pu and 235 The fission product of U is considered to be one of the most harmful nuclides. It is easy to sublime, highly soluble, and exists in various forms (such as inorganic iodine: I2, I 2n+1 - IO3 - ; Organic iodine: CH3I / CH3CH2I, etc.) and redox reaction activity make it easy to migrate and diffuse in the ecosystem, resulting in many challenging problems in the efficient capture of radioactive iodine.

[0003] At present, the main adsorption materials used in nuclear industry technology include silver-impregnated molecular sieves, activated carbon, Al2O3 and SiO2, etc., which are used to treat iodine adsorption in radioactive waste gas and waste liquid. Although the above materials have stable structures, low costs and can be prepared on a large scale, they are generally easy to age, have low iodine adsorption capacity (the adsorption capacity is usually less than 1g / g), relatively slow adsorption kinetics, and are difficult to activate, regenerate and recycle, which greatly limits their practical application.

[0004] In recent years, porous materials with extended network framework structures, such as metal-organic frameworks (MOFs), covalent organic frameworks (COFs), porous organic polymers (POPs), etc., have become ideal research platforms for the development of high-performance iodine adsorption functional materials due to their diverse structures and easy customization, low skeleton density, high specific surface area, rich pore structure and adjustable pore size. However, the strong acidic conditions and high water content in the process of nuclear fission product treatment can easily cause the poor structural stability of MOFs materials, and the performance is reduced or even lost. In addition, COFs and POPs materials are formed by covalent bonds. Although the structural stability is relatively good, there are widespread problems such as poor crystallinity, complex defect structure, and unclear chemical structure during the material synthesis process, which is not conducive to the study of the adsorption mechanism of the iodine adsorption process. It is difficult to reveal the iodine bond cooperation force and rationally guide the design, synthesis and performance optimization of materials. In addition, these polymer materials are usually poorly soluble or even insoluble, which greatly hinders the activation, regeneration, and dissolution processing of the materials.

[0005] Macrocyclic compounds and organic cage molecules are a class of discrete porous molecular materials (PMMs). They usually have inherent cavities that can be customized, stable chemical structures, easy functional modification, and solubility and processing. Compared with framework materials, their clear chemical structures and structural characteristics that can be precisely functionalized are helpful for the study of iodine adsorption mechanisms. In view of this, there is an urgent need to develop new porous functional materials that have high adsorption capacity, fast adsorption kinetics, simple synthesis, high cost-effectiveness, good stability, and easy activation and recycling for efficient capture of iodine. Summary of the invention

[0006] In view of the deficiencies in the prior art, the purpose of the present invention is to provide a hydrogen-bonded aromatic amide molecular cage compound and a preparation method and application thereof, so as to solve the problems of easy aging of radioactive iodine adsorption materials in the prior art, low iodine adsorption capacity, slow adsorption kinetics, poor solubility and poor structural stability.

[0007] The technical solution of the present invention to solve the above technical problems is as follows: a hydrogen-bonded aromatic amide molecular cage compound is provided, and its structural formula is shown in formula (I):

[0008]

[0009] In formula (I), R is X is CH or N.

[0010] The beneficial effects of the present invention are as follows: the hydrogen-bonded aromatic amide molecular cage compound provided by the present invention does not contain metal, is an organic molecule with a clear structure, and has an inherent three-dimensional cavity and a skeleton structure stabilized by intramolecular hydrogen bonds. In the process of adsorbing iodine, the cage-like molecular cavity is enhanced by synergistic non-covalent interactions, or by introducing nitrogen atoms to create active adsorption sites, and the lone pair of electrons on the nitrogen atom can be transferred to the antibonding orbital (σ*) of I2, thereby forming a strong charge transfer complex. At the same time, the pyridine-N atom and the six intramolecular hydrogen-bonded pre-organized carbonyl oxygen atoms act as binding sites in the cavity, which can effectively enhance the binding affinity of the adsorbent material to iodine; by replacing the side chain of the aromatic oligoamide and incorporating additional oxygen atoms into the cage-like molecule, the adsorption capacity of iodine can also be enhanced.

[0011] On the basis of the above technical solution, the present invention can also be improved as follows:

[0012] Furthermore, X is CH, and R is Or, X is N, R is

[0013] The present invention also provides a method for preparing the above hydrogen-bonded aromatic amide molecular cage compound, comprising the following steps:

[0014] S1: Take hydrogen-bonded oligomeric aromatic amide diamine monomer 1 and trialdehyde monomer 2, add organic solvent to dissolve, and obtain a reaction solution; the structural formulas of hydrogen-bonded oligomeric aromatic amide diamine monomer 1 and trialdehyde monomer 2 are as follows, wherein R is X is CH or N;

[0015]

[0016] S2: The reaction solution is stirred at 35-45° C. for 100-140 hours to obtain a reaction solution containing an imine intermediate 1; the structural formula of the imine intermediate 1 is as follows:

[0017]

[0018] S3: adding a reducing agent solution to the reaction solution containing the imine intermediate 1, stirring the reaction for 16 to 20 hours, and removing the solvent by distillation under reduced pressure to obtain a crude product;

[0019] S4: Separate and purify the crude product to obtain.

[0020] On the basis of the above technical solution, the present invention can also be improved as follows:

[0021] Furthermore, the molar ratio of the hydrogen-bonded oligoaramid diamine monomer 1 to the trialdehyde monomer 2 is 3:2.

[0022] Furthermore, the organic solvent is dichloromethane.

[0023] Furthermore, the reducing agent solution is prepared by dissolving NaBH3CN in methanol.

[0024] Furthermore, the specific steps of separation and purification in S4 are: adding anhydrous methanol to the crude product for solid-liquid extraction, and filtering under reduced pressure to obtain a filter residue; thermally dissolving the filter residue with a mixed solution of dichloromethane and methanol, and then adding anhydrous methanol to reprecipitate to obtain a crude product; the crude product is recrystallized using a mixed solution of dichloromethane and methanol, and filtering under reduced pressure to obtain a filter residue, and the filter residue is rinsed with ether.

[0025] Furthermore, the volume ratio of dichloromethane to methanol in the mixed solution of dichloromethane and methanol used for dissolving the filter residue was 20:1, and the volume ratio of dichloromethane to methanol in the mixed solution of dichloromethane and methanol used for recrystallization was 1:1.

[0026] The present invention also provides an application of the hydrogen-bonded aromatic amide molecular cage compound in capturing the radioactive element iodine.

[0027] On the basis of the above technical solution, the present invention can also be improved as follows:

[0028] Furthermore, the radioactive element iodine exists in the form of iodine vapor or an organic iodine compound.

[0029] The present invention has the following beneficial effects:

[0030] 1. The present invention synthesizes an imine intermediate by a dynamic covalent chemical imine condensation reaction of a hydrogen-bonded oligomeric aromatic amide diamine monomer and a trialdehyde monomer in dichloromethane, and then reduces the imine intermediate using NaBH3CN in an in-situ one-pot method to finally obtain an aromatic amide cage molecule. The preparation method is simple and the reaction monomers are cheap and readily available.

[0031] 2. The BET specific surface area of ​​the hydrogen-bonded aromatic amide molecular cage compound prepared by the present invention reaches 645.8 m 2 / g, with high thermal stability and high chemical stability, can be used in harsh environments. Although most current iodine adsorption materials have high adsorption capacity under low temperature (T≤80°C) and high concentration iodine vapor (>10000ppmv) conditions, they are difficult to use under industrial application conditions (T≥150°C, I2 concentration: ~150ppmv). The material prepared by the present invention has excellent iodine vapor capture performance under the above environmental conditions.

[0032] 3. The R1, PyR1 and PyR2 prepared by the present invention are iodine in various forms (including I2, I3 - and CH3I) can be adsorbed efficiently. PyR1 introduced a pyridine-N cap for internal engineering. Due to the synergistic effect of the pyridine-N atom and six intramolecular hydrogen-bonded preorganized carbonyl oxygen atoms as binding sites within its cavity, PyR1 exhibited high affinity, resulting in an iodine adsorption capacity of 5.37 g / g in aqueous solution (equivalent to 56 I2 per cage), 2.17 g / g in cyclohexane, and 9.68 g / g in KI / I2 solution, even in the presence of excess competing anions. PyR2 enhanced the iodine adsorption capacity by incorporating additional oxygen atoms into PyR1 by replacing the side chain of the aromatic oligoamide, which was highly effective for I3 in aqueous solution. - The adsorption capacity of MgCl2O3 was maintained at a high level of about 9.58 g / g and showed an enhanced adsorption capacity of 2.90 g / g in cyclohexane. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 The thermogravimetric analysis diagrams of hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2, where (a) is R1, (b) is PyR1, and (c) is PyR2;

[0034] Figure 2 The iodine vapor adsorption curves of hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 over time, where the inset is the color change of R1 before and after the adsorption of iodine vapor;

[0035] Figure 3It is the pseudo-first-order kinetic fitting diagram of the iodine vapor adsorption curves of hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 changing with time;

[0036] Figure 4 This is a graph showing the adsorption capacity of hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 for methyl iodide as a function of time, where the inset shows the color and property changes of cage R1 before and after the adsorption of methyl iodide. DETAILED DESCRIPTION

[0037] The principles and features of the present invention are described below in conjunction with the examples, which are only used to explain the present invention and are not intended to limit the scope of the present invention. If no specific conditions are specified in the examples, the conditions are carried out according to conventional conditions or the conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be purchased commercially.

[0038] Embodiment 1:

[0039] A hydrogen-bonded aromatic amide molecular cage compound R1, whose structural formula is shown in formula (II):

[0040]

[0041] In formula (II), R is

[0042] The preparation method of the above hydrogen bond aromatic amide molecular cage compound comprises the following steps:

[0043] S1: weigh hydrogen-bonded oligoaramid diamine monomer 1 (0.048 mmol, 3 eq.) and trialdehyde monomer 2 (0.032 mmol, 2 eq.) in a 25 mL Shrek reaction tube, add 10 mL of dry dichloromethane to dissolve, and obtain a reaction solution;

[0044] The structural formulas of hydrogen-bonded oligoaramid diamine monomer 1 and trialdehyde monomer 2 are shown below:

[0045]

[0046] Among them, R is

[0047] S2: The reaction solution was stirred at 40° C. for 5 days, during which the reaction progress was monitored by TLC thin-layer chromatography. When the raw material was completely converted, an insoluble yellow precipitate was generated in the reaction solution, and a reaction solution containing the imine intermediate 1 was obtained;

[0048] The structural formula of the imine intermediate 1 is shown below:

[0049]

[0050] Among them, R is

[0051] S3: Weigh NaBH3CN (24.5 mg, 0.39 mmol) and dissolve it in 2 mL of methanol, then add it to the reaction solution containing the imine intermediate 1, and stir at room temperature to carry out reduction reaction. During the reaction, the yellow insoluble precipitate gradually dissolves, and the solution changes from yellow to light green. After 18 hours of reaction, the reaction progress is monitored by TLC. The imine intermediate 1 completely disappears, and the reaction is stopped. The solvent is removed by distillation under reduced pressure to obtain a crude product.

[0052] S4: Add 30 mL of anhydrous methanol to the obtained crude product, wash twice with solid-liquid extraction, filter under reduced pressure, dissolve the filter residue with 10 mL of CH2Cl2 / MeOH (20 / 1, v / v) mixed solution, and add 30 mL of anhydrous methanol to reprecipitate to obtain a crude product; the crude product is recrystallized using CH2Cl2 / MeOH (1 / 1, v / v), filtered under reduced pressure, and the filter residue is rinsed with 30 mL of ether to obtain a hydrogen-bonded aromatic amide molecular cage compound R1.

[0053] Embodiment 2:

[0054] A hydrogen-bonded aromatic amide molecular cage compound PyR1, whose structural formula is shown in formula (III):

[0055]

[0056] In formula (III), R is

[0057] The preparation method of the above hydrogen bond aromatic amide molecular cage compound comprises the following steps:

[0058] S1: weigh hydrogen-bonded oligoaramid diamine monomer 1 (0.048 mmol, 3 eq.) and trialdehyde monomer 2 (0.032 mmol, 2 eq.) in a 25 mL Shrek reaction tube, add 10 mL of dry dichloromethane to dissolve, and obtain a reaction solution;

[0059] The structural formulas of hydrogen-bonded oligoaramid diamine monomer and trialdehyde monomer are shown below:

[0060]

[0061] Among them, R is

[0062] S2: The reaction solution was stirred at 40° C. for 5 days, during which the reaction progress was monitored by TLC thin-layer chromatography. When the raw material was completely converted, an insoluble yellow precipitate was generated in the reaction solution, and a reaction solution containing the imine intermediate 1 was obtained;

[0063] The structural formula of the imine intermediate 1 is shown below:

[0064]

[0065] Among them, R is

[0066] S3: Weigh NaBH3CN (24.5 mg, 0.39 mmol) and dissolve it in 2 mL of methanol, then add it to the reaction solution containing the imine intermediate 1, and stir at room temperature to carry out reduction reaction. During the reaction, the yellow insoluble precipitate gradually dissolves, and the solution changes from yellow to light green. After 18 hours of reaction, the reaction progress is monitored by TLC. The imine intermediate 1 completely disappears, and the reaction is stopped. The solvent is removed by distillation under reduced pressure to obtain a crude product.

[0067] S4: Add 30 mL of anhydrous methanol to the obtained crude product, wash twice by solid-liquid extraction, filter under reduced pressure, dissolve the filter residue with 10 mL of CH2Cl2 / MeOH (20 / 1, v / v) mixed solution, and add 30 mL of anhydrous methanol to reprecipitate to obtain a crude product; the crude product is recrystallized using CH2Cl2 / MeOH (1 / 1, v / v), filtered under reduced pressure, and the filter residue is rinsed with 30 mL of ether to obtain a hydrogen-bonded aromatic amide molecular cage compound PyR1.

[0068] Embodiment 3:

[0069] A hydrogen-bonded aromatic amide molecular cage compound PyR2, whose structural formula is shown in formula (IV):

[0070]

[0071] In formula (IV), R is

[0072] The preparation method of the above hydrogen bond aromatic amide molecular cage compound comprises the following steps:

[0073] S1: weigh hydrogen-bonded oligoaramid diamine monomer 1 (0.048 mmol, 3 eq.) and trialdehyde monomer 2 (0.032 mmol, 2 eq.) in a 25 mL Shrek reaction tube, add 10 mL of dry dichloromethane to dissolve, and obtain a reaction solution;

[0074] The structural formulas of hydrogen-bonded oligoaramid diamine monomer 1 and trialdehyde monomer 2 are shown below:

[0075]

[0076] Among them, R is

[0077] S2: The reaction solution was stirred at 40° C. for 5 days, during which the reaction progress was monitored by TLC thin-layer chromatography. When the raw material was completely converted, an insoluble yellow precipitate was generated in the reaction solution, and a reaction solution containing the imine intermediate 1 was obtained;

[0078] The structural formula of the imine intermediate 1 is shown below:

[0079]

[0080] Among them, R is

[0081] S3: Weigh NaBH3CN (24.5 mg, 0.39 mmol) and dissolve it in 2 mL of methanol, then add it to the reaction solution containing the imine intermediate 1, and stir at room temperature to carry out reduction reaction. During the reaction, the yellow insoluble precipitate gradually dissolves, and the solution changes from yellow to light green. After 18 hours of reaction, the reaction progress is monitored by TLC. The imine intermediate 1 completely disappears, and the reaction is stopped. The solvent is removed by distillation under reduced pressure to obtain a crude product.

[0082] S4: Add 30 mL of anhydrous methanol to the obtained crude product, wash twice by solid-liquid extraction, filter under reduced pressure, dissolve the filter residue with 10 mL of CH2Cl2 / MeOH (20 / 1, v / v) mixed solution, and add 30 mL of anhydrous methanol to reprecipitate to obtain a crude product; the crude product is recrystallized using CH2Cl2 / MeOH (1 / 1, v / v), filtered under reduced pressure, and the filter residue is rinsed with 30 mL of ether to obtain a hydrogen-bonded aromatic amide molecular cage compound PyR2.

[0083] Experimental example:

[0084] 1. Structural testing

[0085] The hydrogen-bonded aromatic amide molecular cage compound R1 prepared in Example 1 was characterized by hydrogen nuclear magnetic resonance spectrum, carbon nuclear magnetic resonance spectrum and high-resolution mass spectrometry:

[0086] R1 (light yellow solid, 71%). 1H NMR (400MHz, CDCl3, 298K) δ9.90 (s, 6H), 9.16 (s, 3H), 8.27 (d, J = 2.8Hz, 6H), 7.81 (s, 6 H),7.72(d,J=8.2Hz,12H),7.52(d,J=8.0Hz,12H),6.80(d,J=8.8Hz,6H),6.55(s,3H), 6.41(dd,J=8.7,2.8Hz,6H),4.33(s,12H),4.11(q,J=9.1,7.4Hz,12H),3.83(s,18H), 2.10–1.98(m,6H),1.49–1.42(m,48H),0.95(t,J=7.4Hz,18H),0.88(t,J=7.0Hz,18H);

[0087] 13 C NMR (100MHz, CDCl3, 298K) δ162.34,160.10,142.99,141.89,141.26,140.16,138.58,138.15,129.30,128.85,128.81,128.50,127.49 ,124.87,116.15,110.90,107.65,105.91,96.52,72.78,56.05,49.25,38.65,30.16,29.72,28.92,23.57,23.05,14.06,10.67,1.04;

[0088] HRMS: m / z calculated for C 168 H 198 N 12 O 18 [M+2H] 2+ 1337.2563; found1337.2683.

[0089] The hydrogen-bonded aromatic amide molecular cage compound PyR1 prepared in Example 2 was characterized by hydrogen nuclear magnetic resonance spectrum and carbon nuclear magnetic resonance spectrum:

[0090] PyR1 (light red solid, 59%). 1H NMR (400MHz, CDCl3, 298K) δ9.81 (s, 6H), 9.11 (s, 3H), 8.87 (d, J = 2.4Hz, 6H), 8.26 (d, J=2.8Hz,6H),7.97–7.94(m,6H),7.74(s,6H),7.53(d,J=8.2Hz,6H),6.77(d,J=8.7H z,6H),6.54(s,3H),6.42(dd,J=8.7,2.9Hz,6H),4.51(s,12H),4.12(dd,J=6.5,3.4H z,12H),3.81(s,18H),2.02(t,J=6.3Hz,6H),1.56–1.29(m,48H),0.97–0.84(m,36H).

[0091] 13 C NMR (100MHz, CDCl3, 298K) δ162.58,147.34,142.13,141.38,136.00,128.54,125.82,122.45,115.77,72.75 ,55.91,49.60,49.38,49.17,48.95,48.74,48.53,48.32,38.67,30.10,28.86,23.51,22.90,13.86,10.56.

[0092] The hydrogen-bonded aromatic amide molecular cage compound PyR2 prepared in Example 3 was characterized by hydrogen nuclear magnetic resonance spectrum:

[0093] PyR2 (light red solid, 87%). 1 H NMR (400MHz, CDCl3, 298K) δ9.97 (s, 6H), 9.11 (s, 3H), 8.85 (d, J = 2.4Hz, 6H), 8.21 (d, J = 2.8Hz, 6H), 7.98 (dd,J=8.1,2.3Hz,6H),7.75(s,6H),7.55(d,J=8.3Hz,6H),6.79(d,J=8.8Hz,6H),6.73(s,3H),6.42(dd ,J=8.8,2.7Hz,6H),4.50(s,12H),4.43(d,J=5.2Hz,12H),4.01(t,J=5.1Hz,12H),3.85(s,18H),3.70(d d,J=5.9,3.5Hz,12H),3.58(ddd,J=12.0,5.2,2.9Hz,24H),3.47(dd,J=5.8,3.4Hz,12H),3.33(s,18H).

[0094] 2. Thermogravimetric analysis test

[0095] The three hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 prepared in Examples 1 to 3 were subjected to thermogravimetric analysis. Figure 1 The thermogravimetric analysis curves of the three molecular cage compounds show that the three molecular cage compounds have excellent thermal stability, and their thermal decomposition temperatures are all higher than 340°C, which is much higher than the industrial treatment conditions for radioactive iodine adsorption (150°C).

[0096] 3. Iodine vapor adsorption experiment

[0097] The three hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 prepared in Examples 1 to 3 were used for the adsorption of iodine vapor at a temperature of 75° C. for a time of 4 to 40 h.

[0098] The iodine vapor adsorption curves of the three molecular cage compounds over time are shown in Figure 2. Figure 2 As shown, the iodine adsorption capacity of PyR1 and PyR2 is greater than that of R1. It can be seen that the introduction of pyridine adsorption sites into the molecular cage framework can greatly increase its adsorption capacity for iodine vapor.

[0099] The pseudo-first-order kinetics fitting was performed and the following results were obtained:

[0100] The pseudo-first-order kinetic model is: ln(Q e -Q t )=lnQ e -k1t, where Q e and Q t represent the adsorption amount (wt%) when reaching equilibrium and at time t (min); k1 (min -1 ) represents the pseudo-first-order kinetic constant.

[0101] The relevant data are summarized in Table 1:

[0102] Table 1 Adsorption kinetics fitting results of hydrogen-bonded aromatic amide molecular cage compounds

[0103] parameter R1 PyR1 PyR2 <![CDATA[Q e (wt%)]]> 421.14 508.38 523.58 <![CDATA[k1(min -1 )]]> 0.00507 0.01764 0.00603 <![CDATA[R 2 ]]> 0.98635 0.99068 0.991

[0104] Figure 3 The pseudo-first-order kinetic fitting of the iodine vapor adsorption curves of R1, PyR1 and PyR2 over time is given by Figure 3 From the data in Table 1, it can be seen that the adsorption rate PyR1 is the largest, followed by PyR2, and R1 is the smallest; while the adsorption capacity PyR2 is the largest, followed by PyR1, and R1 is the smallest.

[0105] 4. Iodine adsorption experiment in cyclohexane phase

[0106] The three hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 prepared in Examples 1 to 3 were used as adsorbents for iodine adsorption in the cyclohexane phase. The adsorption capacity was determined using a 2.5 mg / mL (10 mM) I2 cyclohexane solution. Accurately weigh 4 mg of adsorbents R1, PyR1 and PyR2 and place them in 15 mL vials respectively. Use a pipette to transfer 10 mL of I2 cyclohexane solution to the vial containing the adsorbent. Make two groups in parallel for each adsorbent. Add a stirring bar to each vial, cover and tighten the lid, and stir at room temperature for 48 hours. Take the supernatant and dilute it 5 times for UV-visible light testing. Select the absorbance at 570 nm for concentration conversion. Calculate the adsorption capacity of the adsorbent according to formula (1):

[0107]

[0108] Where C is the adsorption capacity, V0 is the volume of the I2 cyclohexane solution initially added, and A is the absorbance of the diluted solution at 570 nm after adsorption.

[0109] The adsorption capacity of three molecular cage compounds for organic phase iodine is shown in Table 2:

[0110] Table 2. Determination results of the adsorption capacity of hydrogen-bonded aromatic amide molecular cage compounds on I2 cyclohexane solution

[0111]

[0112] Comparing the adsorption capacity of R1 and PyR1, it can be seen that the introduction of pyridine adsorption sites into the molecular cage skeleton can increase the adsorption capacity of the material for organic phase iodine. Furthermore, comparing the adsorption capacity of PyR1 and PyR2, it can be seen that modifying a large number of O adsorption sites in the side chain of the molecular cage can also further increase the adsorption capacity of the material for organic phase iodine.

[0113] 5. KI3 adsorption experiment in aqueous phase

[0114] The three hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 prepared in Examples 1 to 3 were used as adsorbents for KI3 adsorption in the aqueous phase, and a 30 mg / mL KI3 aqueous solution was used to determine the adsorption capacity. Accurately weigh 4 mg of adsorbents R1, PyR1 and PyR2 and place them in 15 mL vials respectively. Use a pipette to transfer 10 mL of KI3 aqueous solution to the vial containing the adsorbent. Two groups are made in parallel for each adsorbent. Add a stirring bar to each vial, cover and tighten the lid, and stir at room temperature for 48 hours. Filter out the adsorbent solids and wash with water several times until the filtrate is colorless. Combine the filtrates and titrate with 0.05 M sodium bisulfite solution. Add 1 mL of 2% starch indicator when the titration endpoint is approaching, and continue titrating until the solution changes from blue to colorless. Calculate the adsorption capacity of the adsorbent according to formula (2):

[0115]

[0116] Where C is the adsorption capacity, V0 is the volume of the KI3 aqueous solution initially added, and V is the volume of the sodium bisulfite solution used to reach the titration endpoint.

[0117] The adsorption capacities of the three molecular cage compounds for aqueous KI3 are shown in Table 3.

[0118] Table 3. Determination results of the maximum adsorption capacity of molecular cage compounds for KI3 aqueous solution

[0119]

[0120] From the data in Table 3, it can be seen that by comparing the adsorption capacity of R1 and PyR1, PyR2, it can be seen that introducing pyridine adsorption sites into the molecular cage skeleton can increase the material's adsorption capacity for organic phase iodine; further, by comparing the adsorption capacity of PyR1 and PyR2, it can be seen that the water phase adsorption capacity of PyR2 is not greatly improved, which may be because water molecules form hydrogen bonds with the side chain O adsorption sites to compete with iodine.

[0121] 6. Methyl iodide vapor (CH3I) adsorption experiment

[0122] The three hydrogen-bonded aromatic amide molecular cage compounds R1, PyR1 and PyR2 prepared in Examples 1 to 3 were used for the adsorption of methyl iodide vapor (CH3I) at a temperature of 75°C and an adsorption time of 140 h.

[0123] The iodine vapor adsorption curves of R1, PyR1 and PyR2 over time are shown in Figure 4 As shown in Figure 2, the adsorption reaches equilibrium in about 50 h, and the maximum adsorption capacity of molecular cage R1 for CH3I can reach 1.93 g g -1 .

[0124] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A hydrogen-bonded aromatic amide molecular cage compound, characterized in that: Its structural formula is shown in formula (I): In formula (I), R is X is CH or N.

2. The hydrogen-bonded aromatic amide molecular cage compound according to claim 1, characterized in that: X is CH, R is Alternatively, X is N, and R is 3. The method for preparing the hydrogen-bonded aromatic amide molecular cage compound according to claim 1 or 2, characterized in that: The following steps are involved: S1: Take hydrogen-bonded oligomeric aromatic amide diamine monomer 1 and trialdehyde monomer 2, add organic solvent to dissolve, and obtain a reaction solution; the structural formulas of the hydrogen-bonded oligomeric aromatic amide diamine monomer 1 and trialdehyde monomer 2 are as follows, wherein R is X is CH or N; S2: stirring the reaction solution at 35-45° C. for 100-140 hours to obtain a reaction solution containing an imine intermediate 1; the structural formula of the imine intermediate 1 is as follows: S3: adding a reducing agent solution to the reaction solution containing the imine intermediate 1, stirring the reaction for 16 to 20 hours, and removing the solvent by distillation under reduced pressure to obtain a crude product; S4: Separate and purify the crude product to obtain.

4. The preparation method according to claim 3, characterized in that: The molar ratio of the hydrogen-bonded oligoaramid diamine monomer 1 to the trialdehyde monomer 2 is 3:

2.

5. The preparation method according to claim 3, characterized in that: The organic solvent is dichloromethane.

6. The preparation method according to claim 3, characterized in that: The reducing agent solution is prepared by dissolving NaBH3CN in methanol.

7. The preparation method according to claim 3, characterized in that: The specific steps of separation and purification in S4 are: adding anhydrous methanol to the crude product for solid-liquid extraction, and filtering under reduced pressure to obtain a filter residue; using a mixed solution of dichloromethane and methanol to heat dissolve the filter residue, and then adding anhydrous methanol to reprecipitate to obtain a crude product; the crude product is recrystallized using a mixed solution of dichloromethane and methanol, and filtering under reduced pressure to obtain a filter residue, and the filter residue is rinsed with ether.

8. The preparation method according to claim 7, characterized in that: The volume ratio of dichloromethane to methanol in the mixed solution of dichloromethane and methanol used for dissolving the filter residue is 20:1, and the volume ratio of dichloromethane to methanol in the mixed solution of dichloromethane and methanol used for recrystallization is 1:

1.

9. Use of the hydrogen-bonded aromatic amide molecular cage compound according to claim 1 or 2 in capturing the radioactive element iodine.

10. The use according to claim 9, characterized in that: The radioactive element iodine exists in the form of iodine vapor or organic iodine compound.

Citation Information

Patent Citations

  • Preparation method of ionic porous organic cage material applied to radioactive iodine adsorption under high-temperature and low-concentration conditions

    CN114456337A

  • Aromatic amide molecular cage material as well as preparation method and application thereof

    CN118184929A

  • Method for removing / adsorbing iodate ion

    JP2012250198A

Cited By

  • Synthetic method and application of efficient iodine adsorption material

    CN120479383A

  • Synthesis method and application of high-efficiency iodine adsorption material

    CN120479383B

  • Porous organic cage for proton transmission, preparation method of porous organic cage and bioelectronic device

    CN122502378A